PRODUCTS

HOW IS MEDLOOM DIFFERENT?

How is Medloom different from Micromedex, Epocrates, and other systems?

These medical reference systems provide essential drug-drug information at the point-of-care. They also allow a healthcare professional to determine if there is any information known within drug labels about a specified Adverse Drug Reaction (ADR) for any specific drug or combination of drugs. Isn’t that all that Medloom does? Frankly, NO.

While that information is essential, it is insufficient. If it were sufficient, then the FDA would not continue to receive in excess of 1.5 million reports of preventable ADRs every year. What’s missing is a system that can find information related to ADRs even when no drug-drug interactions can be found. That’s MedloomTM.

What’s missing is a system that will find information about an ADR even if you fail to specify it exactly as it is written in the drug label. That’s Medloom’s embedded MobsterTM search term expansion technology.

What’s missing is a system that makes use of real-world, real-time ADR reports using post-marketing safety surveillance (pharmacovigilance) to help you assess risk and make a more informed treatment decision for a patient with a complex polypharmacy and co-morbidity profile. That’s Medloom’s Safety SonarTM.

What’s missing is a DSS that can provide artificial intelligence-assisted identification of clinically significant associations between any adverse event and any drug or combination of drugs based on its real-world safety surveillance. That’s Medloom’s ArdvarcTM AI technology.

Such a system may have prevented the 28,000 deaths associated with the Cox-2 inhibitor Vioxx when it was prescribed for joint pain in patients with a background of heart disease. The information about that contraindication was in the Vioxx drug label for years prior to the drug being withdrawn from the market in September of 2004, but it wasn’t discoverable in a timely manner at the point-of-care. Such a system is now available with Medloom. Making that information discoverable in near real-time is possible through Medloom because if its basis in the world’s fastest database. That’s InterSystems CachéTM.

Medloom is a web-based, Decision Support System that focuses on deciphering drug-patient interactions by making use of background symptomology – as in the Vioxx scenario described above. Medloom also allows you to specify an ADR such as “liver toxicity”, but then it actually searches its myriad drug safety data sources with hundreds of related ADR terms that are automatically generated by new technology (developed at Lead Horse) which links ADR queries to SNOMED-CT and other clinical term ontologies. Though it is web-based, Medloom answers are usually returned within seconds because it is built on the world’s fastest database – InterSystems Caché. That’s the system under the hood at the VA’s VistA EMR system, at EPIC systems, in the IDX EMR that’s now a part of GE Healthcare, at Inter Mountain Healthcare (IMC), at Geisinger Health, and in more than 60% of the world’s Heath IT systems.

Medloom already integrates the complete Medispan drug safety information database from Wolters Kluwer Health (WKH), as well as WKH’s integrated Facts and Comparisons (iFC) suite. Moreover, Medloom integrates the world’s most complete database of safety information related to herbal supplements from Natural Standard, and it’s the only point-of-care decision support system to do so. And Medloom integrates international drug safety data – initially from the EMEA’s counterpart to US MedGuides for the Patient (e.g., EPAR Summaries for the Public), but also, upon launch in Europe in 2010, international, real-time ADR queries/reports. That means that when you ask if anyone has ever seen a specific ADR associated with a new drug – perhaps one that was just approved in the US , Medloom will be able to tell you that, yes, Medloom has received 16 reports, from around the US, or around the globe if you choose, of heart failure associated with that drug in the last 24 hours, particularly when used in patients like yours – perhaps with a background of diabetes, or heart disease, or asthma. (Medloom also integrates the US MedGuides as well.)

Micromedex, Epocrates, and a few other point-of-care medical reference systems do what they do very well, and Medloom was not developed to replace them. Micromedex and Epocrates are great sources of alerts and expert opinions, as well. But they remain, evidently, insufficient to prevent the 100,000 deaths occurring in the U.S. each year due to preventable ADRs. The web-based Medloom Decision Support System was designed to address that unmet medical need. Medloom represents a higher standard in clinical decision support. The time is now to make it your standard. Call us about embedding Medloom as a web app in your own health IT system.

LHT’s Pipeline for drug safety technology:

A new product or patent app. every year!

(FROM MICROMEDEX, EPOCRATES, AND OTHERS)